Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00346632 · ClinicalTrials.gov registry record · Phase 1
An Ascending Dose Study of KW-2449 in Acute Leukemias, Myelodysplastic Syndromes, and Chronic Myelogenous Leukemia
A Phase 1 study, sponsored by Kyowa Kirin.
- Terminated
- Registry status
- Phase 1
- Development phase
- 37
- Enrollment target
NCT00346632 is a Phase 1 study that was terminated before completion, run by Kyowa Kirin. The registered enrollment target is 37 participants.
The verdict
NCT00346632, a Phase 1 study, was terminated before completion, sponsored by Kyowa Kirin.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 37 participants
- Enrollment target
Study Summary
Non-randomized, open, dose ranging and dose scheduling study of ascending doses of KW-2449 in subjects with AML, ALL, MDS and CML.
Interventions
- DRUG KW-2449
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2006-06 |
| Est. Completion | 2008-04 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00346632
The ClinicalTrials.gov registry entry for NCT00346632 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kyowa Kirin, which has 34 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which KW-2449 is the first listed.
NCT00346632 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00346632 about?
NCT00346632 is a clinical study titled "An Ascending Dose Study of KW-2449 in Acute Leukemias, Myelodysplastic Syndromes, and Chronic Myelogenous Leukemia". Non-randomized, open, dose ranging and dose scheduling study of ascending doses of KW-2449 in subjects with AML, ALL, MDS and CML.
What is the current status of trial NCT00346632?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 37 participants. The study started on 2006-06. Estimated completion is 2008-04.
What interventions are being tested in trial NCT00346632?
The interventions under investigation include: KW-2449 (DRUG).
Who is sponsoring clinical trial NCT00346632?
This trial is sponsored by Kyowa Kirin, which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.